Hepatitis Monthly

Published by: Kowsar

Hepatic Shock Differential Diagnosis and Risk Factors: A Review Article

Hassan Soleimanpour 1 , Saeid Safari 2 , Farzad Rahmani 3 , Arezu Nejabatian 4 and Seyed Moayed Alavian 5 , 6 , *
Authors Information
1 Cardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, IR Iran
2 Department of Anesthesiology, Iran University of Medical Sciences, Tehran, IR Iran
3 Road Traffic Injury Research Center, Tabriz University of Medical Sciences, Tabriz, IR Iran
4 Students’ Research Committee, Tabriz University of Medical Sciences, Tabriz, IR Iran
5 Baqiyatallah Research Center for Gastroenterology and Liver Diseases, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
6 Department of Molecular Hepatology, Middle East Liver Disease Center, Tehran, IR Iran
Article information
  • Hepatitis Monthly: October 01, 2015, 15 (10); e27063
  • Published Online: October 10, 2015
  • Article Type: Review Article
  • Received: January 17, 2015
  • Revised: June 19, 2015
  • Accepted: August 4, 2015
  • DOI: 10.5812/hepatmon.27063

To Cite: Soleimanpour H, Safari S, Rahmani F, Nejabatian A, Alavian S M. Hepatic Shock Differential Diagnosis and Risk Factors: A Review Article, Hepat Mon. 2015 ; 15(10):e27063. doi: 10.5812/hepatmon.27063.

Copyright © 2015, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Evidence Acquisition
3. Results
4. Conclusions
  • 1. Eipel C, Abshagen K, Vollmar B. Regulation of hepatic blood flow: the hepatic arterial buffer response revisited. World J Gastroentero. 2010; 16(48): 6046
  • 2. Seeto RK, Fenn B, Rockey DC. Ischemic hepatitis: clinical presentation and pathogenesis. Am J Med. 2000; 109(2): 109-13
  • 3. Emmanuel A, Inns S. Ischemic/Hypoxic Hepititis. Lecture Notes: Gastroenterology and Hepatology. 2002; : 1024-100
  • 4. Fuhrmann V, Jager B, Zubkova A, Drolz A. Hypoxic hepatitis - epidemiology, pathophysiology and clinical management. Wien Klin Wochenschr. 2010; 122(5-6): 129-39[DOI][PubMed]
  • 5. Soultati A, Dourakis SP. Liver dysfunction in the intensive care unit. Ann Gastroenterol. 2007; 18(1): 35-45
  • 6. Drolz A, Horvatits T, Roedl K, Fuhrmann V. [Shock liver and cholestatic liver in critically ill patients]. Med Klin Intensivmed Notfmed. 2014; 109(4): 228-34[DOI][PubMed]
  • 7. Chavez-Tapia NC, Balderas-Garces BV, Meza-Meneses P, Herrera-Gomar M, Garcia-Lopez S, Gonzalez-Chon O, et al. Hypoxic hepatitis in cardiac intensive care unit: a study of cardiovascular risk factors, clinical course, and outcomes. Ther Clin Risk Manag. 2014; 10: 139-45[DOI][PubMed]
  • 8. Deng W, Farricielli L. Hypoxic hepatitis and acute liver failure in a patient with newly onset atrial fibrillation and diltiazem infusion. BMJ Case Rep. 2013; 2013[DOI][PubMed]
  • 9. Strassburg CP. Gastrointestinal disorders of the critically ill. Shock liver. Best Pract Res Clin Gastroenterol. 2003; 17(3): 369-81[PubMed]
  • 10. Birrer R, Takuda Y, Takara T. Hypoxic hepatopathy: pathophysiology and prognosis. Intern Med. 2007; 46(14): 1063-70[PubMed]
  • 11. Henrion J, Schapira M, Luwaert R, Colin L, Delannoy A, Heller FR. Hypoxic hepatitis: clinical and hemodynamic study in 142 consecutive cases. Medicine (Baltimore). 2003; 82(6): 392-406[DOI][PubMed]
  • 12. Kwok W, Clemens MG. Rho-kinase activation contributes to Lps-induced impairment of endothelial nitric oxide synthase activation by endothelin-1 in cultured hepatic sinusoidal endothelial cells. Shock. 2014; 42(6): 554-61[DOI][PubMed]
  • 13. Baveja R, Kresge N, Ashburn JH, Keller S, Yokoyama Y, Sonin N, et al. Potentiated hepatic microcirculatory response to endothelin-1 during polymicrobial sepsis. Shock. 2002; 18(5): 415-22[PubMed]
  • 14. Targher G, Byrne CD. Circulating Markers of Liver Function and Cardiovascular Disease Risk. Arterioscler Thromb Vasc Biol. 2015; [DOI][PubMed]
  • 15. Memis D, Inal MT, Sut N. The effects of levosimendan vs dobutamine added to dopamine on liver functions assessed with noninvasive liver function monitoring in patients with septic shock. J Crit Care. 2012; 27(3): 318 e1-6[DOI][PubMed]
  • 16. Matsushima H, Soyama A, Takatsuki M, Hidaka M, Muraoka I, Kuroki T, et al. The outcomes of patients with severe hyperbilirubinemia following living donor liver transplantation. Dig Dis Sci. 2013; 58(5): 1410-4[DOI][PubMed]
  • 17. Wei H, Wu H, Yu W, Yan X, Zhang X. Shenfu decoction as adjuvant therapy for improving quality of life and hepatic dysfunction in patients with symptomatic chronic heart failure. J Ethnopharmacol. 2015; 169: 347-55[DOI][PubMed]
  • 18. Haddad JJ. Discordant tissue-specific expression of SAPK/MAPK(JNK)-related cofactors in hypoxia and hypoxia/reoxygenation in a model of anoxia-tolerance. Protein Pept Lett. 2007; 14(4): 373-80[PubMed]
  • 19. Vincent JL. Organ dysfunction in patients with severe sepsis. Surg Infect (Larchmt). 2006; 7 Suppl 2-72[DOI][PubMed]
  • 20. Guilbert T, Odin C, Le Grand Y, Gailhouste L, Turlin B, Ezan F, et al. A robust collagen scoring method for human liver fibrosis by second harmonic microscopy. Opt Express. 2010; 18(25): 25794-807[DOI][PubMed]
  • 21. National Heart L, Blood Institute ACTN, Truwit JD, Bernard GR, Steingrub J, Matthay MA, et al. Rosuvastatin for sepsis-associated acute respiratory distress syndrome. N Engl J Med. 2014; 370(23): 2191-200[DOI][PubMed]
  • 22. Szypowska A, Skorka A, Pankowska E. Acute hypoxic hepatopathy: diabetic ketoacidosis complication in an infant newly diagnosed with type 1 diabetes mellitus. Pediatr Endocrinol Diabetes Metab. 2008; 14(4): 249-51[PubMed]
  • 23. Du LY, Tang H. Treatment of HCV patients before and after renal transplantation. Hepat Mon. 2011; 11(11): 880-6[DOI][PubMed]
  • 24. Hauser SC. Cecil Medicine. 2011;
  • 25. Temiz MZ, Yuruk E, Teberik K, Akbas BK, Piroglu MD, Oztorun HS, et al. Ischemic hepatitis after percutaneous nephrolitotomy: A case report. Int J Surg Case Rep. 2014; 5(12): 1258-60[DOI][PubMed]
  • 26. Camara-Lemarroy CR. Remote ischemic preconditioning as treatment for non-ischemic gastrointestinal disorders: beyond ischemia-reperfusion injury. World J Gastroenterol. 2014; 20(13): 3572-81[DOI][PubMed]
  • 27. Li C, Li YS, Xu M, Wen SH, Yao X, Wu Y, et al. Limb remote ischemic preconditioning for intestinal and pulmonary protection during elective open infrarenal abdominal aortic aneurysm repair: a randomized controlled trial. Anesthesiology. 2013; 118(4): 842-52[DOI][PubMed]
  • 28. Soleimanpour H, Safari S, Rahmani F, Jafari Rouhi A, Alavian SM. Intravenous hypnotic regimens in patients with liver disease; a review article. Anesth Pain Med. 2015; 5(1)[DOI][PubMed]
  • 29. Khongphatthanayothin A, Mahayosnond A, Poovorawan Y. Possible cause of liver failure in patient with dengue shock syndrome. Emerg Infect Dis. 2013; 19(7): 1161-3[DOI][PubMed]
  • 30. Hsu JT, Chen TH, Chiang KC, Kuo CJ, Lin CJ, Yeh TS. Role of p38 MAPK pathway in 17beta-estradiol-mediated attenuation of hemorrhagic shock-induced hepatic injury. J Appl Physiol (1985). 2015; 118(2): 187-92[DOI][PubMed]
  • 31. Tanaka M, Tanaka K, Masaki Y, Miyazaki M, Kato M, Kotoh K, et al. Intrahepatic microcirculatory disorder, parenchymal hypoxia and NOX4 upregulation result in zonal differences in hepatocyte apoptosis following lipopolysaccharide- and D-galactosamine-induced acute liver failure in rats. Int J Mol Med. 2014; 33(2): 254-62[DOI][PubMed]
  • 32. Knight B, Matthews VB, Akhurst B, Croager EJ, Klinken E, Abraham LJ, et al. Liver inflammation and cytokine production, but not acute phase protein synthesis, accompany the adult liver progenitor (oval) cell response to chronic liver injury. Immunol Cell Biol. 2005; 83(4): 364-74[DOI][PubMed]
  • 33. Duong HT, Dong Z, Su L, Boyer C, George J, Davis TP, et al. The use of nanoparticles to deliver nitric oxide to hepatic stellate cells for treating liver fibrosis and portal hypertension. Small. 2015; 11(19): 2291-304[DOI][PubMed]
  • 34. Luo B, Liu L, Tang L, Zhang J, Ling Y, Fallon MB. ET-1 and TNF-alpha in HPS: analysis in prehepatic portal hypertension and biliary and nonbiliary cirrhosis in rats. Am J Physiol Gastrointest Liver Physiol. 2004; 286(2)-303[DOI][PubMed]
  • 35. Chen CF, Wang D, Leu FJ, Chen HI. The protective role of nitric oxide and nitric oxide synthases in whole-body hyperthermia-induced hepatic injury in rats. Int J Hyperthermia. 2012; 28(5): 421-30[DOI][PubMed]
  • 36. Rostami Z, Nourbala MH, Alavian SM, Bieraghdar F, Jahani Y, Einollahi B. The impact of Hepatitis C virus infection on kidney transplantation outcomes: A systematic review of 18 observational studies: The impact of HCV on renal transplantation. Hepat Mon. 2011; 11(4): 247-54[PubMed]
  • 37. Einollahi B. Therapy for HBV Infection in Hemodialysis Patients: Is it Possible? Hepat Mon. 2012; 12(3): 153-7[DOI][PubMed]
  • 38. Kumpf VJ. Parenteral nutrition-associated liver disease in adult and pediatric patients. Nutr Clin Pract. 2006; 21(3): 279-90[PubMed]
  • 39. Soreide E, Harboe S, Sondenaa K. Severe ARDS may cause right heart failure with extreme hepatomegaly but without hepatic failure. Acta Anaesthesiol Scand. 2002; 46(7): 906-7[PubMed]
  • 40. Pannen BH, Kohler N, Hole B, Bauer M, Clemens MG, Geiger KK. Protective role of endogenous carbon monoxide in hepatic microcirculatory dysfunction after hemorrhagic shock in rats. J Clin Invest. 1998; 102(6): 1220-8[DOI][PubMed]
  • 41. Harbrecht BG, Wu B, Watkins SC, Billiar TR, Peitzman AB. Inhibition of nitric oxide synthesis during severe shock but not after resuscitation increases hepatic injury and neutrophil accumulation in hemorrhaged rats. Shock. 1997; 8(6): 415-21[PubMed]
  • 42. Liu FC, Yu HP, Hwang TL, Tsai YF. Protective effect of tropisetron on rodent hepatic injury after trauma-hemorrhagic shock through P38 MAPK-dependent hemeoxygenase-1 expression. PLoS One. 2012; 7(12)[DOI][PubMed]
  • 43. Hurt RT, Zakaria el R, Matheson IPJ, Cobb ME, Parker JR, Garrison RN. Hemorrhage-Induced Hepatic Injury and Hypoperfusion can be Prevented by Direct Peritoneal Resuscitation. J Gastrointest Surg. 2009; 13(4): 587-94
  • 44. Champion HR, Jones RT, Trump BF, Decker R, Wilson S, Miginski M, et al. A clinicopathologic study of hepatic dysfunction following shock. Surg Gynecol Obstet. 1976; 142(5): 657-63[PubMed]
  • 45. Heller AR, Heller SC, Borkenstein A, Stehr SN, Koch T. Modulation of host defense by hydrocortisone in stress doses during endotoxemia. Intensive Care Med. 2003; 29(9): 1456-63[DOI][PubMed]
  • 46. Da J, Chen L, Hedenstierna G. Nitric oxide up-regulates the glucocorticoid receptor and blunts the inflammatory reaction in porcine endotoxin sepsis. Crit Care Med. 2007; 35(1): 26-32[DOI][PubMed]
  • 47. Sharshar T, Blanchard A, Paillard M, Raphael JC, Gajdos P, Annane D. Circulating vasopressin levels in septic shock. Crit Care Med. 2003; 31(6): 1752-8[DOI][PubMed]
  • 48. Spapen H. Liver perfusion in sepsis, septic shock, and multiorgan failure. Anat Rec (Hoboken). 2008; 291(6): 714-20[DOI][PubMed]
  • 49. Dang CN, Ohdachi SD, Nguyen NX, Pham TD, Boldbaatar B, Satoh H. Possible cause of liver failure in patient with dengue shock syndrome. Emerg Infect Dis. 2013; 19(7): 1161-3[DOI][PubMed]
  • 50. Einollahi B, Ghadian A, Ghamar-Chehreh E, Alavian SM. Non-viral related liver enzymes elevation after kidney transplantation. Hepat Mon. 2014; 14(2)[DOI][PubMed]
  • 51. Mohseni M, Safari S, Alavian SM. Volatile anesthetics in ischemic liver injury: enemy or friend? Hepat Mon. 2014; 14(6)[DOI][PubMed]
  • 52. Bechstein WO, Dette K, Wullstein C, Golling M. [Intensive care treatment of post-traumatic liver failure]. Kongressbd Dtsch Ges Chir Kongr. 2002; 119: 405-9[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments